This brand name is authorized in France, Malta
The drug MAGNEVIE B6 contains a combination of these active pharmaceutical ingredients (APIs):
|
1
Pyridoxine
UNII 68Y4CF58BV - PYRIDOXINE HYDROCHLORIDE
|
|
Pyridoxine hydrochloride is Vitamin B6. It is converted to pyridoxal phosphate which is the co-enzyme for a variety of metabolic transformations. It is essential for human nutrition. |
|
2
Magnesium citrate
UNII RHO26O1T9V - MAGNESIUM CITRATE
|
|
|
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
| ATC code | Group title | Classification |
|---|---|---|
| A12 | Mineral supplements | A Alimentary tract and metabolism |
This drug has been assigned below unique identifiers within the countries it is being marketed:
| Country | Identification scheme | Identifier(s) |
|---|---|---|
| Country: FR | Base de données publique des médicaments | Identifier(s): 66383154 |
| Country: MT | Medicines Authority | Identifier(s): AA1470/01501 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
